HomeTagsDrug

drug

SGX-LISTED COMPANIES

Tianjin Pharmaceutical Da Ren Tang Is Shrinking To Succeed In FY2025

How TJ DRT’s 33% Revenue "Loss" Fueled a 72% Margin Miracle and a Record...
SGX-LISTED COMPANIES

Why China Medical Systems FY2025 Profits Dropped Despite Growth

https://open.spotify.com/episode/3YAldvdzS4eXE4RzkN9M18?si=8a54594510534cfe 5 Game-Changing Takeaways from CMS’s 2025 Transformation For the Chinese pharmaceutical sector, 2025 was the...
SGX-LISTED COMPANIES

iX Biopharma’s Secret Shortcut To The US Medical Market – 1H FY2026

From Cash Burn to Bioavailability: How iX Biopharma Slashed Losses by 67% via a...
SGX-LISTED COMPANIES

iX Biopharma’s Robust FY2025 Performance and Strategic Outlook

iX Biopharma LTD achieved robust financial performance with significant revenue and gross profit growth,...
spot_img

Latest articles

SGX-LISTED COMPANIES

Metasurface Technologies Expands Regional Footprint With SGX Catalist Listing

Listing Overview Precision component engineering provider Metasurface Technologies Holdings Limited is expanding its capital markets...
SGX-LISTED COMPANIES

Lion Asiapac Stays Profitable In Q1 2026 But Core Segment Challenges Lurk Beneath Surface

Lion Asiapac Q1 2026 Results Reveal Hidden Strengths and Clear Red Flags for Investors Investors...
SGX-LISTED COMPANIES

Miyoshi Limited Cuts FY2026 Net Losses By Half But Liquidity Risks Loom Large

Shrinking Losses Amid Operational Shift and Liquidity Hurdles Miyoshi Limited has officially released its full-year...
AI

NusaVest targets US$2B ABSs to ease digital economy funding squeeze

NusaVest is aiming to facilitate at least US$2 billion in asset-backed securities transactions over...